Endocrine Testing Market Size, Share & Trends Analysis Report By Test Type, By Technology (Tandem Mass Spectrometry, Immunoassay), By End-use And Segment Forecasts, 2013 - 2024

Published: Mar, 2018 | Pages: 114 | Publisher: Grand View Research
Industry: Medical Devices | Report Format: Electronic (PDF)

The global endocrine testing market is expected to reach USD 13.02 billion by 2025, according to a new report by Grand View Research, Inc. Increasing geriatric population and growing rate of diseases such as obesity and diabetes is expected to drive the market growth.

The presence of a large population over 60 years, having lower immunity levels and are prone to neurological diseases, cardiac problems, cancers, and spinal injuries, is a high impact-rendering driver for the growth of endocrine testing market over the forecast period.

Sedentary lifestyles of people with unhealthy food habits and increasing stress levels resulted in an increase in the diabetic and obese population. This demographic is highly susceptible to endocrine diseases and is anticipated to contribute to industry growth substantially.

Technological advancements in terms of accuracy and affordability resulted in an increased usage of these tests. For instance, the influx of test kits, for home-based testing has fostered the demand for these techniques, helping the market to grow. Advancement in technology ensures diagnosis in less time and faster initiation of treatment.

Software have been designed to manage the workflow in the laboratories. Newer mobile apps have been introduced wherein a patient can be reminded about his appointment or test, and he will be able to contact physician whenever he wants. These advancements in technology is anticipated to propel the market growth over the forecast period.

Further key findings from the report suggest:

• The global thyroid stimulating hormone testing market is anticipated to reach 3.6 billion by 2024, at a CAGR of 10.2% from 2016 to 2024

• In terms of test type, insulin test is expected to show the fastest growth over the forecast period

• In terms of technology, Tandem Mass Spectrometry (TMS) held the largest share in 2016 and is expected to dominate the market during the forecast period

• In terms of technology, sensor technology is expected to show the fastest growth during the forecast period

• North America is expected to dominate the market followed by Europe and Asia Pacific region

• Asia Pacific is projected to drive the market growth and provide numerous opportunities to industry players. Key factors attributed to market growth include growing R&D expenditure by the government and private agencies in order to improve diagnostic and therapeutic areas in the region

• Some of the key companies present in the market include Abbott Laboratories, AB Sciex, Agilent Technologies, Biomedical Technologies, bioMerieux SA, Bio Rad Laboratories, DiaSorin, Hoffmann-La Roche Ltd., LabCorp, and Quest Diagnostics.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources
Chapter 2. Executive Summary
2.1. Endocrine Testing Market - Industry Snapshot and Key Buying Criteria, 2015
Chapter 3. Endocrine Testing Industry Outlook
3.1. Market Segmentation
3.2. Endocrine Testing Market Size and Growth Prospects
3.3. Endocrine Testing Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.4. Key Opportunities Prioritized
3.5. Industry Analysis - Porter's
3.6. Endocrine Testing Company Market Share/Competitive Landscape, 2015
3.7. Endocrine Testing Market PESTEL Analysis, 2015
Chapter 4. Endocrine Testing Market-Test Type
4.1. Endocrine Testing Market Share, by Test Type, 2015 & 2024
4.2. Estradiol (E2) Test
4.2.1. Estradiol (E2) Test Market Estimates and Forecasts, 2013 - 2024 (USD Million)
4.3. Follicle Stimulating Hormone(FSH) Test
4.3.1. Follicle Stimulating Hormone(FSH) Test Market Estimates and Forecasts, 2013 - 2024 (USD Million)
4.4. Human Chorionic Gonadotropin (hCG) Test
4.4.1. Human Chorionic Gonadotropin (hCG) Test Market Estimates and Forecasts, 2013 - 2024 (USD Million)
4.5. Luteinizing Hormone (LH) Test
4.5.1. LH Test Market Estimates and Forecasts, 2013 - 2024 (USD Million)
4.6. Dehydroepiandrosterone sulfate (DHEAS) Test
4.6.1. DHEAS Test Market Estimates and Forecasts, 2013 - 2024 (USD Million)
4.7. Progesterone Test
4.7.1. Progesterone Test Market Estimates and Forecasts, 2013 - 2024 (USD Million)
4.8. Testosterone Test
4.8.1. Testosterone Test Market Estimates and Forecasts, 2013 - 2024 (USD Million)
4.9. Thyroid Stimulating Hormone (TSH) Test
4.9.1. Thyroid Stimulating Hormone (TSH) Test Market Estimates and Forecasts, 2013 - 2024 (USD Million)
4.10. Prolactin Test
4.10.1. Prolactin Test Market Estimates and Forecasts, 2013 - 2024 (USD Million)
4.11. Cortisol Test
4.11.1. Cortisol Test Market Estimates and Forecasts, 2013 - 2024 (USD Million)
4.12. Insulin Test
4.12.1. Insulin Test Market Estimates and Forecasts, 2013 - 2024 (USD Million)
4.13. Other Tests
4.13.1. Other Test Market Estimates and Forecasts, 2013 - 2024 (USD Million)
Chapter 5. Endocrine Testing Market by Diagnostic Technology
5.1. Endocrine Testing Market Share, by Diagnostic Technology, 2015 & 2024
5.2. Tandem Mass Spectrometry
5.2.1. Tandem Mass Spectrometry Market Estimates and Forecasts, 2013 - 2024 (USD Million)
5.3. Immunoassay
5.3.1. Immunoassay Market Estimates and Forecasts, 2013 - 2024 (USD Million)
5.4. Monoclonal and Polyclonal Antibody Technologies
5.4.1. Monoclonal and Polyclonal Antibody Technologies Market Estimates and Forecasts, 2013 - 2024 (USD Million)
5.5. Sensor Technologies
5.5.1. Sensor Technologies Market Estimates and Forecasts, 2013 - 2024 (USD Million)
5.6. Clinical Chemistry Technologies
5.6.1. Clinical Chemistry Technologies Market Estimates and Forecasts, 2013 - 2024 (USD Million)
5.7. Others
5.7.1. Others Market Estimates and Forecasts, 2013 - 2024 (USD Million)
Chapter 6. Endocrine Testing Market by End-Use
6.1. Endocrine Testing Market Share, by End Use, 2015 & 2024
6.2. Hospitals
6.2.1. Hospitals Market Estimates and Forecasts, 2013 - 2024 (USD Million)
6.3. Commercial Laboratories
6.3.1. Commercial Laboratories Market Estimates and Forecasts, 2013 - 2024 (USD Million)
6.4. Ambulatory Care Centres
6.4.1. Ambulatory Care Centres Market Estimates and Forecasts, 2013 - 2024 (USD Million)
6.5. Other Settings
6.5.1. Other Settings Market Estimates and Forecasts, 2013 - 2024 (USD Million)
Chapter 7. Endocrine Testing Market by Region
7.1. Endocrine Testing Market Share, by Region, 2015 & 2024
7.2. North America
7.2.1. North America Market Estimates and Forecasts, by test type 2013 - 2024 (USD Million)
7.2.1.1. U.S. Market Estimates and Forecasts
7.2.1.2. Canada Market Estimates and Forecasts
7.2.2. North America Market Estimates and Forecasts, by Technology 2013 - 2024 (USD Million)
7.2.2.1. U.S. Market Estimates and Forecasts
7.2.2.2. Canada Market Estimates and Forecasts
7.2.3. North America Market Estimates and Forecasts, by End Use 2013 - 2024 (USD Million)
7.2.3.1. U.S. Market Estimates and Forecasts
7.2.3.2. Canada Market Estimates and Forecasts
7.3. Europe
7.3.1. Europe Market Estimates and Forecasts, by test type, 2013 - 2024 (USD Million)
7.3.1.1. UK Market Estimates and Forecasts
7.3.1.2. Germany Market Estimates and Forecasts
7.3.2. Europe Market Estimates and Forecasts, by Technology, 2013 - 2024 (USD Million)
7.3.2.1. UK Market Estimates and Forecasts
7.3.2.2. Germany Market Estimates and Forecasts
7.3.3. Europe Market Estimates and Forecasts, by End Use, 2013 - 2024 (USD Million)
7.3.3.1. UK Market Estimates and Forecasts
7.3.3.2. Germany Market Estimates and Forecasts
7.4. Asia Pacific
7.4.1. Asia Pacific Market Estimates and Forecasts, by test type, 2013 - 2024 (USD Million)
7.4.1.1. Japan Market Estimates and Forecasts
7.4.1.2. China Market Estimates and Forecasts
7.4.2. Asia Pacific Market Estimates and Forecasts, by Technology, 2013 - 2024 (USD Million)
7.4.2.1. Japan Market Estimates and Forecasts
7.4.2.2. China Market Estimates and Forecasts
7.4.3. Asia Pacific Market Estimates and Forecasts, by End Use, 2013 - 2024 (USD Million)
7.4.3.1. Japan Market Estimates and Forecasts
7.4.3.2. China Market Estimates and Forecasts
7.5. Latin America
7.5.1. Latin America Market Estimates and Forecasts, by test type, 2013 - 2024 (USD Million)
7.5.1.1. Brazil Market Estimates and Forecasts
7.5.1.2. Mexico Market Estimates and Forecasts
7.5.2. Latin America Market Estimates and Forecasts, by Technology, 2013 - 2024 (USD Million)
7.5.2.1. Brazil Market Estimates and Forecasts
7.5.2.2. Mexico Market Estimates and Forecasts
7.5.3. Latin America Market Estimates and Forecasts, by End Use, 2013 - 2024 (USD Million)
7.5.3.1. Brazil Market Estimates and Forecasts
7.5.3.2. Mexico Market Estimates and Forecasts
7.6. Middle East
7.6.1. Middle East Market Estimates and Forecasts, by test type, 2013 - 2024 (USD Million)
7.6.1.1. South Africa Market Estimates and Forecasts
7.6.1.2. Saudi Arabia Market Estimates and Forecasts
7.6.2. Middle East Market Estimates and Forecasts, by Technology, 2013 - 2024 (USD Million)
7.6.2.1. South Africa Market Estimates and Forecasts
7.6.2.2. Saudi Arabia Market Estimates and Forecasts
7.6.3. Middle East Market Estimates and Forecasts, by End Use, 2013 - 2024 (USD Million)
7.6.3.1. South Africa Market Estimates and Forecasts
7.6.3.2. Saudi Arabia Market Estimates and Forecasts
Chapter 8. Competitive Landscape
8.1. Abbott Laboratories
8.1.1. Company Overview
8.1.2. Financial Performance
8.1.3. Product Benchmarking
8.1.4. Strategic Initiatives
8.2. AB Sciex Pte. Ltd.
8.2.1. Company Overview
8.2.2. Financial Performance
8.2.3. Product Benchmarking
8.2.4. Strategic Initiatives
8.3. Agilent Technologies
8.3.1. Company Overview
8.3.2. Financial Performance
8.3.3. Product Benchmarking
8.3.4. Strategic Initiatives
8.4. Biomedical Technologies.
8.4.1. Company Overview
8.4.2. Financial Performance
8.4.3. Product Benchmarking
8.4.4. Strategic Initiatives
8.5. bioMerieux SA
8.5.1. Company Overview
8.5.2. Financial Performance
8.5.3. Product Benchmarking
8.5.4. Strategic Initiatives
8.6. Bio-Rad Laboratories.
8.6.1. Company Overview
8.6.2. Financial Performance
8.6.3. Product Benchmarking
8.6.4. Strategic Initiatives
8.7. DiaSorin S.p.A.
8.7.1. Company Overview
8.7.2. Financial Performance
8.7.3. Product Benchmarking
8.7.4. Strategic Initiatives
8.8. F. Hoffmann-La Roche Ltd.
8.8.1. Company Overview
8.8.2. Financial Performance
8.8.3. Product Benchmarking
8.8.4. Strategic Initiatives
8.9. LabCorp
8.9.1. Company Overview
8.9.2. Financial Performance
8.9.3. Product Benchmarking
8.9.4. Strategic Initiatives
8.10. Ortho Clinical Technology
8.10.1. Company Overview
8.10.2. Financial Performance
8.10.3. Product Benchmarking
8.10.4. Strategic Initiatives
8.11. Quest Technology
8.11.1. Company Overview
8.11.2. Financial Performance
8.11.3. Product Benchmarking
8.11.4. Strategic Initiatives
8.12. Siemens Healthcare
8.12.1. Company Overview
8.12.2. Financial Performance
8.12.3. Product Benchmarking
8.12.4. Strategic Initiatives
8.13. Sysmex Corporation.
8.13.1. Company Overview
8.13.2. Financial Performance
8.13.3. Product Benchmarking
8.13.4. Strategic Initiatives
8.14. Thermo Fisher Scientific, Inc.
8.14.1. Company Overview
8.14.2. Financial Performance
8.14.3. Product Benchmarking
8.14.4. Strategic Initiatives

List of Tables

TABLE 1 Endocrine testing market - Industry Summary & Key Buying Criteria 
TABLE 2 Endocrine testing market, by test type, 2013 - 2024 (USD million)
TABLE 3 Endocrine testing market, by technology, 2014 - 2024 (USD million)
TABLE 4 Endocrine testing market, by end-use, 2013 - 2024 (USD million)
TABLE 5 Endocrine testing market, by region, 2013 - 2024 (USD Million)
TABLE 6 Endocrine testing - Key market driver analysis
TABLE 7 Endocrine testing - Key market restraint analysis
TABLE 8 North America endocrine testing market, by region 2013 - 2024 (USD Million)
TABLE 9 North America endocrine testing market, by test type 2013 - 2024 (USD Million)
TABLE 10 North America endocrine testing market, by technology 2013 - 2024 (USD Million)
TABLE 11 North America endocrine testing market, by end-use 2013 - 2024 (USD Million)
TABLE 12 U.S.endocrine testing market, by test type 2013 - 2024 (USD Million)
TABLE 13 U.S. endocrine testing market, by technology 2013 - 2024 (USD Million)
TABLE 14 U.S. endocrine testing market, by end-use 2013 - 2024 (USD Million)
TABLE 15 Canada America endocrine testing market, by test type 2015 - 2024 (USD Million)
TABLE 16 Canada endocrine testing market, by technology 2013 - 2024 (USD Million)
TABLE 17 Canada endocrine testing market, by end-use 2013 - 2024 (USD Million)
TABLE 18 Europe endocrine testing market, by region 2013 - 2024 (USD Million)
TABLE 19 Europe endocrine testing market, by test type 2013 - 2024 (USD Million)
TABLE 20 Europe endocrine testing market, by technology 2013 - 2024 (USD Million)
TABLE 21 Europe endocrine testing market, by end-use 2013 - 2024 (USD Million)
TABLE 22 UK endocrine testing market, by test type 2013 - 2024 (USD Million)
TABLE 23 UK endocrine testing market, by technology 2013 - 2024 (USD Million)
TABLE 24 UK endocrine testing market, by end-use 2013 - 2024 (USD Million)
TABLE 25 Germany endocrine testing market, by test type 2013 - 2024 (USD Million)
TABLE 26 Germany endocrine testing market, by technology 2013 - 2024 (USD Million)
TABLE 27 Germany endocrine testing market, by end-use 2013 - 2024 (USD Million)
TABLE 28 Asia Pacific endocrine testing market, by region 2013 - 2024 (USD Million)
TABLE 29 Asia Pacific endocrine testing market, by test type 2013 - 2024 (USD Million)
TABLE 30 Asia Pacific endocrine testing market, by technology 2013 - 2024 (USD Million)
TABLE 31 Asia Pacific endocrine testing market, by end-use 2013 - 2024 (USD Million)
TABLE 32 Japan endocrine testing market, by test type 2013 - 2024 (USD Million)
TABLE 33 Japan endocrine testing market, by technology 2013 - 2024 (USD Million)
TABLE 34 Japan endocrine testing market, by end-use 2013 - 2024 (USD Million)
TABLE 35 China endocrine testing market, by test type 2013 - 2024 (USD Million)
TABLE 36 China endocrine testing market, by technology 2013 - 2024 (USD Million)
TABLE 37 China endocrine testing market, by end-use 2013 - 2024 (USD Million)
TABLE 38 Latin America endocrine testing market, by region 2013 - 2024 (USD Million)
TABLE 39 Latin America endocrine testing market, by test type 2013 - 2024 (USD Million)
TABLE 40 Latin America endocrine testing market, by technology 2013 - 2024 (USD Million)
TABLE 41 Latin America endocrine testing market, by end-use 2013 - 2024 (USD Million)
TABLE 42 Brazil endocrine testing market, by test type 2013 - 2024 (USD Million)
TABLE 43 Brazil endocrine testing market, by technology 2013 - 2024 (USD Million)
TABLE 44 Brazil endocrine testing market, by end-use 2013 - 2024 (USD Million)
TABLE 45 Mexico endocrine testing market, by test type 2013 - 2024 (USD Million)
TABLE 46 Mexico endocrine testing market, by technology 2013 - 2024 (USD Million)
TABLE 47 Mexico endocrine testing market, by end-use 2013 - 2024 (USD Million)
TABLE 48 MEA endocrine testing market, by region 2013 - 2024 (USD Million)
TABLE 49 MEA endocrine testing market, by test type 2013 - 2024 (USD Million)
TABLE 50 MEA endocrine testing market, by technology 2013 - 2024 (USD Million)
TABLE 51 MEA endocrine testing market, by end-use 2013 - 2024 (USD Million)
TABLE 52 South Africa endocrine testing market, by test type 2013 - 2024 (USD Million)
TABLE 53 South Africa endocrine testing market, by technology 2013 - 2024 (USD Million)
TABLE 54 South Africa endocrine testing market, by end-use 2013 - 2024 (USD Million)
TABLE 55 Saudi Arabia endocrine testing market, by test type 2013 - 2024 (USD Million)
TABLE 56 Saudi Arabia endocrine testing market, by technology 2013 - 2024 (USD Million)
TABLE 57 Saudi Arabia endocrine testing market, by end-use 2013 - 2024 (USD Million)

List of Figures

FIG. 1 Global endocrine testing: Market segmentation
FIG. 2 Global endocrine testing market, 2013 - 2024 (USD Million)
FIG. 3 Endocrine testing: Market dynamics
FIG. 4 Endocrine testing market - Porter's analysis
FIG. 5 Key opportunities prioritized
FIG. 6 Endocrine testing market - PESTEL Analysis
FIG. 7 Endocrine testing market share, by test type, 2015 & 2024
FIG. 8 Estradiol test market, 2013 - 2024 (USD Million)
FIG. 9 Follicle Stimulating Hormone market, 2013 - 2024 (USD Million)
FIG. 10 Human Chorionic Gonadotropin test market, 2013 - 2024 (USD Million)
FIG. 11 Luteinizing hormone test market, 2013 - 2024 (USD Million)
FIG. 12 Dehydroepiandrosterone sulfate test market, 2013 - 2024 (USD Million)
FIG. 13 Progesterone test market, 2013 - 2024 (USD Million)
FIG. 14 Testosterone test market, 2013 - 2024 (USD Million)
FIG. 15 Thyroid Stimulating Hormone test market, 2013 - 2024 (USD Million)
FIG. 16 Prolactin test market, 2013 - 2024 (USD Million)
FIG. 17 Cortisol test market, 2013 - 2024 (USD Million)
FIG. 18 Insulin test market, 2013 - 2024 (USD Million)
FIG. 19 Other test market, 2013 - 2024 (USD Million)
FIG. 20 Endocrine testing market share, by technology, 2015 &2024
FIG. 21 Tandem mass spectrometry market, 2013 - 2024 (USD Million)
FIG. 22 Immunoassay market, 2013 - 2024 (USD Million)
FIG. 23 Monoclonal and polyclonal antibodies market, 2013 - 2024 (USD Million)
FIG. 24 Sensor technology market, 2013 - 2024 (USD Million)
FIG. 25 Clinical chemistry market, 2013 - 2024 (USD Million)
FIG. 26 Other technology market, 2013 - 2024 (USD Million)
FIG. 27 Endocrine testing market share, by end-use, 2015 &2024
FIG. 28 Hospitals market, 2013 - 2024 (USD Million)
FIG. 29 Commercial laboratories market, 2013 - 2024 (USD Million)
FIG. 30 Ambulatory care centers market, 2013 - 2024 (USD Million)
FIG. 31 Other settings market, 2013 - 2024 (USD Million)
FIG. 32 Endocrine testing market share, by region, 2015 &2024
FIG. 33 North America endocrine testing market, 2013 - 2024 (USD Million)
FIG. 34 U.S. endocrine testing market, 2013 - 2024 (USD Million)
FIG. 35 Canada endocrine testing market, 2013 - 2024 (USD Million)
FIG. 36 Europe endocrine testing market, 2013 - 2024 (USD Million)
FIG. 37 UK endocrine testing market, 2013 - 2024 (USD Million)
FIG. 38 Germany endocrine testing market, 2013 - 2024 (USD Million)
FIG. 39 Asia Pacific endocrine testing market, 2013 - 2024 (USD Million)
FIG. 40 Japan endocrine testing market, 2013 - 2024 (USD Million)
FIG. 41 China endocrine testing market, 2013 - 2024 (USD Million)
FIG. 42 Latin America endocrine testing market, 2013 - 2024 (USD Million)
FIG. 43 Brazil endocrine testing market, 2013 - 2024 (USD Million)
FIG. 44 Mexico endocrine testing market, 2013 - 2024 (USD Million)
FIG. 45 MEA endocrine testing market, 2013 - 2024 (USD Million)
FIG. 46 South Africa endocrine testing market, 2013 - 2024 (USD Million)
FIG. 47 Saudi Arabia endocrine testing market, 2013 - 2024 (USD Million)